In line with that, p53-deficient PC-3 cells are also resistant to treatment with chrysosplenol d [33], whereas NSCLC A549 expressing wild type p53 (p53wt) are particularly sensitive to chrysosplenol d. This evidence concerns the gene TP53 and non-small cell lung carcinoma.